Cyclerion Therapeutics Inc (CYCN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.31
• Market Cap: $4.72M
• EPS: $-0.70
• 52-Week High: $3.79
• 52-Week Low: $1.03

Market Sentiment

Cyclerion Therapeutics Inc currently has a Bullish sentiment score of 0.42.

About Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, specializing in the discovery and development of innovative therapeutics for serious central nervous system (CNS) disorders. The company leverages its proprietary technology platform to develop a promising pipeline aimed at addressing significant unmet medical needs, particularly in cognitive impairment and related CNS diseases. Cyclerion's focus on advancing treatment options ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cyclerion Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CYCN pay dividends?

Cyclerion Therapeutics Inc (CYCN) does not currently pay a regular dividend.

What is CYCN's market cap?

Cyclerion Therapeutics Inc (CYCN) has a market capitalization of $4.72M with a current stock price of $1.31.